Background: Successful clinical evaluation of human tumors relies on proper handling of tissue samples to maximally preserve the cellular and metabolic states in vivo. Pancreatic samples are particularly sensitive to sample mishandling due to the abundance of digestive enzymes. We study how the duration of ischemia, in vivo and ex vivo, both of which are unavoidable lagging periods following surgical dissection, significantly impact the utility of pancreatic samples.
Methods: We systematically characterize a wide range of tissue integrity features, including histological patterns, cellular structures, DNA/RNA quality and activity of major signaling pathways in normal pancreases and pancreatic ductal adenocarcinoma (PDAC) tumor tissues from 41 patients with different ischemia.
Results: We reveal that tissues experiencing longer periods of ischemia exhibit significant deterioration and could potentially mislead disease diagnosis and preclinical research. Based on these analyses, we propose an optimal procedure that balances better clinical practice and high tissue sample quality.
Conclusions: Our work provides a guideline for pancreatic sample handling and could have wide implications in clinical diagnosis and translational research.
Keywords: Ex vivo ischemic time; In vivo ischemic time; Normal pancreas; Pancreatic ductal adenocarcinoma; Tissue handling.
Copyright © 2019 IAP and EPC. Published by Elsevier B.V. All rights reserved.